Chris Bunge

Analyst-Equity at

Opaleye Management, Inc.

Finance

Consumer Services

Profile

Chris Bunge is currently a Senior Analyst at Opaleye Management, Inc. since 2023.
Formerly, Mr. Bunge was a Portfolio Manager at WaterMill Asset Management from 2017 to 2024 and an Analyst at Manalapan Oracle Advisers LLC from 2013 to 2014.
Mr. Bunge completed an undergraduate degree at Bentley University in 2013.

Chris Bunge active positions

Companies	Position	Start
Opaleye Management, Inc. Opaleye Management, Inc. Investment ManagersFinance Opaleye employs a research process that involves analyzing company fundamentals, such as asset valuations, quality of management, likely catalysis and/ or innovative products and the competition. The firm’s strategy for managing the Fund is to actively invest, both long and short, in equity securities of US and foreign small and mid-cap biotechnology, specialty pharmaceutical and med-device companies.	Analyst-Equity	31/10/2023

All active positions of Chris Bunge

Former positions of Chris Bunge

Companies	Position	End
WaterMill Asset Management WaterMill Asset Management Investment ManagersFinance WaterMill Asset Management invests in both private and public companies.	Portfolio Manager-Equities	31/12/2023
Manalapan Oracle Advisers LLC Manalapan Oracle Advisers LLC Investment ManagersFinance Profile Unavailable.	Analyst-Equity	31/03/2014

See the detail of Chris Bunge's experience

Training of Chris Bunge

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Chris Bunge's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Bentley University Bentley University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Opaleye Management, Inc. Opaleye Management, Inc. Investment ManagersFinance Opaleye employs a research process that involves analyzing company fundamentals, such as asset valuations, quality of management, likely catalysis and/ or innovative products and the competition. The firm’s strategy for managing the Fund is to actively invest, both long and short, in equity securities of US and foreign small and mid-cap biotechnology, specialty pharmaceutical and med-device companies.	Finance
Manalapan Oracle Advisers LLC Manalapan Oracle Advisers LLC Investment ManagersFinance Profile Unavailable.	Finance
WaterMill Asset Management WaterMill Asset Management Investment ManagersFinance WaterMill Asset Management invests in both private and public companies.	Finance